Aslani, Baby Girl -.
HRN: 22-76-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/19/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/19/2024
10/26/2024
IVTT
100mg
Q8h
Amoebiasis
Waiting Final Action
Indication: Culture-directed Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes